208 related articles for article (PubMed ID: 24403505)
61. Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer.
Lucchetta M; Lonardi S; Bergamo F; Alberti P; Velasco R; Argyriou AA; Briani C; Bruna J; Cazzaniga M; Cortinovis D; Cavaletti G; Kalofonos HP
Cancer Chemother Pharmacol; 2012 Dec; 70(6):899-902. PubMed ID: 23108696
[TBL] [Abstract][Full Text] [Related]
62. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
Beijers AJ; Jongen JL; Vreugdenhil G
Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
[TBL] [Abstract][Full Text] [Related]
63. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
64. Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening.
Rana P; Luerman G; Hess D; Rubitski E; Adkins K; Somps C
Toxicol In Vitro; 2017 Dec; 45(Pt 1):111-118. PubMed ID: 28843493
[TBL] [Abstract][Full Text] [Related]
65. [Neurotoxic effects of medications: an update].
Arné-Bès MC
Rev Med Liege; 2004; 59 Suppl 1():118-23. PubMed ID: 15244167
[TBL] [Abstract][Full Text] [Related]
66. Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.
Mohrmann C; Armer J; Hayashi RJ
J Pediatr Oncol Nurs; 2017; 34(2):106-114. PubMed ID: 27251891
[TBL] [Abstract][Full Text] [Related]
67. Chemotherapy-induced peripheral neurotoxicity: how can we improve knowledge?
Cavaletti G
Lancet Oncol; 2009 Jun; 10(6):539-40. PubMed ID: 19482244
[No Abstract] [Full Text] [Related]
68. Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss.
Pasquariello KZ; Dey JM; Sprowl JA
Mol Pharmacol; 2021 Oct; 100(4):348-355. PubMed ID: 34330821
[TBL] [Abstract][Full Text] [Related]
69. Anticancer Drugs and the Nervous System.
Santomasso BD
Continuum (Minneap Minn); 2020 Jun; 26(3):732-764. PubMed ID: 32487905
[TBL] [Abstract][Full Text] [Related]
70. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.
Huang KM; Leblanc AF; Uddin ME; Kim JY; Chen M; Eisenmann ED; Gibson AA; Li Y; Hong KW; DiGiacomo D; Xia SH; Alberti P; Chiorazzi A; Housley SN; Cope TC; Sprowl JA; Wang J; Loprinzi CL; Noonan A; Lustberg MB; Cavaletti G; Pabla N; Hu S; Sparreboom A
J Clin Invest; 2020 Sep; 130(9):4601-4606. PubMed ID: 32484793
[TBL] [Abstract][Full Text] [Related]
71. Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations.
Oldenburg J; Fosså SD
Acta Oncol; 2009; 48(6):804-6. PubMed ID: 19484592
[No Abstract] [Full Text] [Related]
72. [Mechanisms of platinum-induced peripheral neuropathy in cancer patients].
Chubykina SV; Tatarinova MY; Avakyan GG
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):19-24. PubMed ID: 37490661
[TBL] [Abstract][Full Text] [Related]
73. Acute oxaliplatin-induced peripheral-nerve hyperexcitability.
Schmelz R; Lersch C
J Clin Oncol; 2002 Aug; 20(16):3561-2; author reply 3562. PubMed ID: 12177120
[No Abstract] [Full Text] [Related]
74. Cancer-treatment-induced neurotoxicity--focus on newer treatments.
Stone JB; DeAngelis LM
Nat Rev Clin Oncol; 2016 Feb; 13(2):92-105. PubMed ID: 26391778
[TBL] [Abstract][Full Text] [Related]
75. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity.
Pozzi E; Alberti P
Methods Mol Biol; 2022; 2547():95-140. PubMed ID: 36068462
[TBL] [Abstract][Full Text] [Related]
76. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.
Cavaletti G
J Peripher Nerv Syst; 2014 Jun; 19(2):66-76. PubMed ID: 24976572
[TBL] [Abstract][Full Text] [Related]
77. The role of sulfur in platinum anticancer chemotherapy.
Wang And X; Guo Z
Anticancer Agents Med Chem; 2007 Jan; 7(1):19-34. PubMed ID: 17266503
[TBL] [Abstract][Full Text] [Related]
78. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M; Juranek JK; Zygulska AL
Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
[TBL] [Abstract][Full Text] [Related]
79. New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants.
Gatti L; Cassinelli G; Zaffaroni N; Lanzi C; Perego P
Drug Resist Updat; 2015 May; 20():1-11. PubMed ID: 26003720
[TBL] [Abstract][Full Text] [Related]
80. The double-edged sword: Neurotoxicity of chemotherapy.
Magge RS; DeAngelis LM
Blood Rev; 2015 Mar; 29(2):93-100. PubMed ID: 25445718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
